SCHEMBL2447478

SCHEMBL2447478

CN(C)N(CCCCCCC(=O)NO)C(=O)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 12/20 0.62
HDAC1 Q13547 10/20 0.59
HDAC3 O15379 4/20 0.59
HDAC2 Q92769 4/20 0.59
HDAC8 Q9BY41 6/20 0.57
HDAC4 P56524 1/20 0.56
HDAC7 Q8WUI4 1/20 0.56
HDAC10 Q969S8 1/20 0.56
HDAC11 Q96DB2 1/20 0.56
HDAC9 Q9UKV0 1/20 0.56
HDAC5 Q9UQL6 1/20 0.56
NCOR2 Q9Y618 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28215034 1.00 HDAC6 (0.62) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL1232674 0.94 HDAC6 (0.55) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL15525296 0.86 HDAC6 (0.81) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL10906612 0.84 HDAC6 (0.50) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL10903602 0.79 HDAC3 (0.47) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL6386623 0.78 HDAC6 (0.77) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL2227202 0.77 HDAC6 (1.00) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL6384657 0.77 HDAC6 (0.75) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL2226798 0.76 HDAC6 (1.00) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL2227725 0.76 HDAC6 (1.00) HDAC6HDAC1HDAC3HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2544673-A1 THIOXANTHONE-BASED AUTOPHAGY INHIBITOR THERAPIES TO TREAT CANCER Spectrum Pharmaceuticals, Inc. (US) 2013-01-16 EP disclosed
WO-2011112623-A1 THIOXANTHONE-BASED AUTOPHAGY INHIBITOR THERAPIES TO TREAT CANCER SPECTRUM PHARMACEUTICALS, INC. (US) 2011-09-15 WO disclosed